[go: up one dir, main page]

TW200519099A - Novel amines as histamine-3 receptor ligands and their therapeutic applications - Google Patents

Novel amines as histamine-3 receptor ligands and their therapeutic applications

Info

Publication number
TW200519099A
TW200519099A TW093141278A TW93141278A TW200519099A TW 200519099 A TW200519099 A TW 200519099A TW 093141278 A TW093141278 A TW 093141278A TW 93141278 A TW93141278 A TW 93141278A TW 200519099 A TW200519099 A TW 200519099A
Authority
TW
Taiwan
Prior art keywords
histamine
receptor ligands
therapeutic applications
novel amines
amines
Prior art date
Application number
TW093141278A
Other languages
Chinese (zh)
Other versions
TWI333489B (en
Inventor
Marlon D Cowart
Youssef L Bennani
Ramin Faghih
Gregory A Gfesser
Lawrence A Black
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/810,648 external-priority patent/US20020177589A1/en
Priority claimed from US10/044,495 external-priority patent/US20020183309A1/en
Priority claimed from US10/081,207 external-priority patent/US6969730B2/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of TW200519099A publication Critical patent/TW200519099A/en
Application granted granted Critical
Publication of TWI333489B publication Critical patent/TWI333489B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compounds of formula (I), or a pharmaceutically -acceptable salt, ester, amide, or prodrug thereof, which are useful for the modulation of the histamine-3 receptors in mammals and which are useful for the treatment of disorders ameliorated by histamine-3 receptor ligands.
TW93141278A 2001-03-16 2002-03-15 Novel amines as histamine-3 receptor ligands and their therapeutic applications TWI333489B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/810,648 US20020177589A1 (en) 2001-03-16 2001-03-16 Novel amines as histamine-3 receptor ligands and their therapeutic applications
US10/044,495 US20020183309A1 (en) 2001-03-16 2002-01-11 Novel amines as histamine-3 receptor ligands and their therapeutic applications
US10/081,207 US6969730B2 (en) 2001-03-16 2002-02-25 Amines as histamine-3 receptor ligands and their therapeutic applications

Publications (2)

Publication Number Publication Date
TW200519099A true TW200519099A (en) 2005-06-16
TWI333489B TWI333489B (en) 2010-11-21

Family

ID=38812605

Family Applications (2)

Application Number Title Priority Date Filing Date
TW91104939A TWI335914B (en) 2001-03-16 2002-03-15 Novel amines as histamine-3 receptor ligands and their therapeutic applications
TW93141278A TWI333489B (en) 2001-03-16 2002-03-15 Novel amines as histamine-3 receptor ligands and their therapeutic applications

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW91104939A TWI335914B (en) 2001-03-16 2002-03-15 Novel amines as histamine-3 receptor ligands and their therapeutic applications

Country Status (3)

Country Link
PE (1) PE20020928A1 (en)
TW (2) TWI335914B (en)
UY (1) UY27212A1 (en)

Also Published As

Publication number Publication date
PE20020928A1 (en) 2002-10-26
TWI333489B (en) 2010-11-21
TWI335914B (en) 2011-01-11
UY27212A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
WO2002074758A3 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
TW200407305A (en) Novel compounds
MY135841A (en) Novel benzodioxoles
SE0203713D0 (en) Novel compounds
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
UA87856C2 (en) Alkynyl derivatives as modulators of metatropic glutamate receptors
SE0303180D0 (en) Novel compounds
MXPA03007621A (en) N-substituted nonaryl-heterocyclic nmda/nr2b antagonists.
PL1685105T3 (en) Allosteric modulators of metabotropic glutamate receptors
PL1971601T3 (en) N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
MXPA06000276A (en) Indolinone hydrazides as c-met inhibitors.
MXPA05007115A (en) Novel cb 1 receptor inverse agonists.
PL1696905T3 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
MXPA06009475A (en) Quinazoline derivatives and therapeutic use thereof.
IL176111A0 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
MXPA05013151A (en) 3-fluoro-piperidines as nmda/nr2b antagonists.
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
TW200633984A (en) Amide compounds and activators of thrombopoietin receptor
GB2435190A (en) Gastrin and cholecystokinin receptor ligands
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
SI1845780T1 (en) Uses of methylphenidate derivatives

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees